Rating History for ESSA Pharma (EPIX) by Piper Sandler
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 11/4/2024 | Joseph Catanzaro | Downgrade | Neutral (Overweight) |
2.00 (15.00) |
5.20 (0.20) |
-96.15% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 11/4/2024 | Joseph Catanzaro | Downgrade | Neutral (Overweight) |
2.00 (15.00) |
5.20 (0.20) |
-96.15% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||